Investment Stage

Focus Areas

About Investor

Anne Dobrée is an Investment Director at Parkwalk Advisors in London. She invests in Medical Device and material science companies at the Seed, Series A, and Series B stages. Her work centers on founders translating scientific research and engineering innovation into products with practical healthcare and industrial applications. Anne generally invests between $300K and $5.5M, with a preferred commitment of approximately $3M. As a lead investor, she contributes directly to technical due diligence, financing decisions, and the strategic development of portfolio companies. At Parkwalk Advisors, she helps science-based ventures navigate product development, validation, and commercial expansion.